The list below shows The Lymphoma Group's current clinical trials open for recruitment for Hodgkin lymphoma patients.
- RADAR - testing brentuximab vedotin, combined with chemotherapy, in people with stage 1A or 2A Hodgkin lymphoma who haven’t had treatment before.
- AZD7789 - testing AZD7789 in people with relapsed or refractory classical Hodgkin lymphoma.
With special thanks to the following:
For further information on each trial, please visit the Find a trial page on Lymphoma Action’s website.